Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.abbott.co.in | |
Market Cap | 44,492.43 Cr. | |
Enterprise Value(EV) | 43,415.28 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 414.96 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 50.46 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 30.86 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 1,277.45 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 16.39 | Calculated using Price: 20,938.30 |
Dividend Yield | 1.31 | Period Ending 2022-03 |
No. of Shares Subscribed | 2.12 Cr. | 21,249,302 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India. |
1 Day |
|
-2.24% |
1 Week |
|
+1.57% |
1 Month |
|
-6.57% |
3 Month |
|
+8.21% |
6 Month |
|
+2.47% |
1 Year |
|
+24.76% |
2 Year |
|
+42.13% |
5 Year |
|
+271.14% |
10 Year |
|
+1403.13% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 27.66 | 26.54 | 23.93 | 21.54 | 26.35 | 24.66 | 27.09 | 27.89 | 29.95 | |
Return on Capital Employed (%) | 41.07 | 39.98 | 37.55 | 33.96 | 40.61 | 37.88 | 36.54 | 37.52 | 40.53 | |
Return on Assets (%) | 12.96 | 11.20 | 13.39 | 15.12 | 18.01 | 16.90 | 18.36 | 18.78 | 19.89 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 788 | 938 | 1,196 | 1,387 | 1,693 | 2,009 | 2,432 | 2,602 | 2,820 | 2,714 | |
Non Curr. Liab. | 443 | 432 | 29 | 35 | 41 | 62 | 210 | 190 | 184 | 166 | |
Curr. Liab. | 652 | 834 | 382 | 632 | 668 | 857 | 891 | 1,031 | 1,203 | 1,200 | |
Minority Int. | |||||||||||
Equity & Liab. | 1,883 | 2,204 | 1,607 | 2,053 | 2,402 | 2,928 | 3,532 | 3,823 | 4,207 | 4,081 | |
Non Curr. Assets | 540 | 541 | 156 | 160 | 136 | 167 | 328 | 335 | 354 | 1,102 | |
Curr. Assets | 1,343 | 1,663 | 1,451 | 1,893 | 2,265 | 2,761 | 3,205 | 3,487 | 3,853 | 2,979 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,883 | 2,204 | 1,607 | 2,053 | 2,402 | 2,928 | 3,532 | 3,823 | 4,207 | 4,081 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 2,276 | 2,289 | 2,615 | 2,903 | 3,299 | 3,679 | 4,093 | 4,310 | 4,919 | 5,163 | |
Other Income | 49 | 48 | 51 | 60 | 118 | 114 | 115 | 83 | 77 | 100 | |
Total Income | 2,325 | 2,338 | 2,666 | 2,963 | 3,417 | 3,793 | 4,208 | 4,393 | 4,997 | 5,263 | |
Total Expenditure | -2,009 | -1,978 | -2,251 | -2,508 | -2,775 | -3,075 | -3,337 | -3,391 | -3,832 | -3,987 | |
PBIDT | 317 | 360 | 415 | 455 | 641 | 718 | 871 | 1,002 | 1,165 | 1,276 | |
Interest | 0 | -1 | -3 | -2 | -4 | -2 | -9 | -18 | -19 | -18 | |
Depreciation | -22 | -15 | -14 | -16 | -16 | -17 | -60 | -58 | -66 | -69 | |
Taxation | -96 | -115 | -143 | -160 | -220 | -249 | -210 | -235 | -281 | -308 | |
Exceptional Items | |||||||||||
PAT | 198 | 229 | 255 | 277 | 401 | 450 | 593 | 691 | 799 | 882 | |
Adjusted EPS | 93 | 108 | 120 | 130 | 189 | 212 | 279 | 325 | 376 | 415 |
Particulars | 10 years | 2012-12 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 101 | 155 | 215 | 249 | 307 | 153 | 499 | 626 | 727 | 948 | |
Cash Fr. Inv. | -59 | -144 | -187 | -77 | -155 | -215 | -257 | -401 | -72 | -396 | |
Cash Fr. Finan. | -42 | -42 | -58 | -80 | -90 | -102 | -143 | -217 | -582 | -637 | |
Net Change | 1 | -31 | -30 | 91 | 62 | -165 | 99 | 8 | 73 | -86 | |
Cash & Cash Eqvt | 109 | 79 | 49 | 140 | 202 | 38 | 137 | 145 | 218 | 133 |
No Corporate Announcement found. |
Wed, 08 Feb 2023 |
|
|
|
|
|